REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 26 filers reported holding REVANCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,587,200 | -23.6% | 44,000,000 | 0.0% | 0.02% | -18.2% |
| Q2 2023 | $46,596,000 | -14.0% | 44,000,000 | 0.0% | 0.02% | -18.5% |
| Q1 2023 | $54,186,000 | +22.3% | 44,000,000 | -8.3% | 0.03% | +17.4% |
| Q4 2022 | $44,304,000 | -15.3% | 48,000,000 | 0.0% | 0.02% | -20.7% |
| Q3 2022 | $52,320,000 | +33.9% | 48,000,000 | 0.0% | 0.03% | +52.6% |
| Q2 2022 | $39,060,000 | -13.5% | 48,000,000 | 0.0% | 0.02% | +5.6% |
| Q1 2022 | $45,150,000 | +6.5% | 48,000,000 | 0.0% | 0.02% | +20.0% |
| Q4 2021 | $42,390,000 | -23.4% | 48,000,000 | 0.0% | 0.02% | -28.6% |
| Q3 2021 | $55,363,000 | -1.6% | 48,000,000 | 0.0% | 0.02% | 0.0% |
| Q2 2021 | $56,240,000 | +4.1% | 48,000,000 | 0.0% | 0.02% | -4.5% |
| Q1 2021 | $54,031,000 | – | 48,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 20,087 | $23,535,000 | 2.18% |
| ZAZOVE ASSOCIATES LLC | 15,910,000 | $18,551,000 | 1.66% |
| SSI INVESTMENT MANAGEMENT LLC | 4,487,000 | $5,231,000 | 0.34% |
| DeepCurrents Investment Group LLC | 4,918,000 | $5,752,000 | 0.17% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 3,000,000 | $3,500,000 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 12,500,000 | $14,646,000 | 0.03% |
| Citadel Advisors | 104,329,000 | $122,081,000 | 0.03% |
| LAZARD ASSET MANAGEMENT LLC | 20,000,000 | $23,433,000 | 0.03% |
| WOLVERINE ASSET MANAGEMENT LLC | 2,918,000 | $3,416,000 | 0.03% |
| FRANKLIN RESOURCES INC | 48,000,000 | $56,240,000 | 0.02% |